^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

TXNIP underexpression

i
Other names: TXNIP, Thioredoxin Interacting Protein, VDUP1, EST01027, HHCPA78, ARRDC6, THIF, Upregulated By 1,25-Dihydroxyvitamin D-3, Vitamin D3 Up-Regulated Protein 1, Thioredoxin-Interacting Protein, Thioredoxin Binding Protein 2, Thioredoxin-Binding Protein 2
Entrez ID:
over3years
TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression. (PubMed, Am J Cancer Res)
Further studies found that the tumor suppressor effect of TXNIP was mediated by upregulating DNA damage-inducible transcript 4 (DDIT4) and inhibiting the phosphorylation of mechanistic target of rapamycin complex 1 (mTORC1) downstream substrate S6. Based on the above, our study explored the key role of TXNIP/DDIT4/mTORC1 suppression as a regulatory axis in the progression of OS, and laid the foundation for precise targeted therapy for OS.
Journal
|
TXNIP (Thioredoxin Interacting Protein) • DDIT4 (DNA Damage Inducible Transcript 4)
|
TXNIP underexpression
|
sirolimus
almost4years
Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP. (PubMed, Cell Cycle)
Up-regulated miR-15b-5p further strengthened the pro-tumor effect of EXO, but this effect was reversed by overexpression of TXNIP. Overall, tumor-derived exosomal miR-15b-5p augments LCa through targeting down-regulation of TXNIP.
Journal
|
TXNIP (Thioredoxin Interacting Protein) • MIR15B (MicroRNA 15b)
|
TXNIP underexpression